Immunosuppressive Agents: all 5,940 studies that test it
Page 2 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- PD-1 Inhibitor Combined With Rituximab, Methotrexate, and Orelabrutinib (PD-1i+RMO) for Newly Diagnosed PCNSL and SCNSL.RecruitingNCT07410520Phase 2
- Palatal Wound Healing After Free Gingival Graft SurgeryRecruitingNCT07409571Not applicable
- Adjuvant Intensification for LARNot yet recruitingNCT07407517Phase 3
- Azacitidine and Abatacept in Relapsed or Refractory T-Cell LymphomaRecruitingNCT07388563Phase 1
- A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled GoutRecruitingNCT07388498Phase 3
- Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness StudyRecruitingNCT07381556Phase 4
- Systematic Approach for Children With Orbital Malformation With Sirolimus UseRecruitingNCT07378657Phase 3
- Comparison of Conjunctival Goblet Cell Density in Dry Eye Patients Treated With Cyclosporine 0.1% Dissolved in Perfluorobutylpentane (Vevye®) or Generic 0.05% Cyclosporine Emulsion for 8 WeeksNot yet recruitingNCT07368595Phase 4
- Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic MalignanciesRecruitingNCT07366801Phase 2/3
- Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell CancerNot yet recruitingNCT07361133Phase 2
- A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries.Not yet recruitingNCT07359807Phase 2/3
- Methotrexate for Severe Vulvar Lichen SclerosusRecruitingNCT07352917Phase 2
- Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingNCT07352566Phase 4
- A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSLRecruitingNCT07350850Phase 2
- TCR-T Cell Therapy for KRAS Mutation in Advanced Solid TumorsNot yet recruitingNCT07342738Early Phase 1
- Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null PhenotypeRecruitingNCT07341867Phase 1
- The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil TreatmentRecruitingNCT07340463Phase 2
- To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care HospitalRecruitingNCT07337434Early Phase 1
- A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung DiseaseRecruitingNCT07319598Phase 4
- Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial CancerRecruitingNCT07318324Phase 1
- Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic LeukemiaRecruitingNCT07311746Phase 1/2
- A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular CarcinomaNot yet recruitingNCT07309419Phase 2/3
- TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCTRecruitingNCT07302776Phase 1
- Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALLRecruitingNCT07297914Phase 2/3
- Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior UveitisRecruitingNCT07285070Phase 2
- Does it Matter the Volume of Injectate on the Outcome of Ultrasound-guided Perineural Injection for Carpal Tunnel SyndromeNot yet recruitingNCT07283874Phase 4
- Gene Replacement Therapy for Treatment of Paediatric Patients With CTNNB1 Neurodevelopmental SyndromeRecruitingNCT07270549Phase 1/2
- Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque PsoriasisRecruitingNCT07261306Early Phase 1
- CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and LymphomaRecruitingNCT07257419Phase 1
- Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell TransplantationRecruitingNCT07249346Phase 2
- Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term RemissionNot yet recruitingNCT07248644Phase 4
- Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia GravisRecruitingNCT07246564Phase 4
- TC-G203 for Patients With GPC3-Positive Advanced Solid TumorsRecruitingNCT07242417Early Phase 1
- Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched DonorRecruitingNCT07238712Phase 2
- Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell LymphomaNot yet recruitingNCT07231250Phase 2
- A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) AmyloidosisRecruitingNCT07224672Phase 2
- Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland DysfunctionRecruitingNCT07224529Phase 4
- Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple SclerosisRecruitingNCT07220252Phase 2/3
- Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline MutationsNot yet recruitingNCT07218575Phase 2/3
- Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATGRecruitingNCT07216391Phase 2
- Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme MalignanciesRecruitingNCT07214688Phase 2
- Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.Not yet recruitingNCT07203664Phase 4
- Metastatic Ewing's Trial Testing Schedule Enhancement to Improve OutcomesRecruitingNCT07194044Phase 1
- Reduced Post-transplant Cyclophosphamide Dose in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation for Hematological MalignanciesNot yet recruitingNCT07193420Phase 3
- A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）RecruitingNCT07191431Not applicable
- Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal WomenRecruitingNCT07191353Phase 2
- Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal CarcinomaNot yet recruitingNCT07189572Phase 3
- Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCHRecruitingNCT07187193Phase 2
- Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHDRecruitingNCT07184853Not applicable
- Chemotherapy With Rituximab for Aggressive B-NHL in Children and AdolescentsRecruitingNCT07168980Phase 2/3
- Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine TumorsRecruitingNCT07165886Phase 2/3
- A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKINot yet recruitingNCT07165418Phase 3
- Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic DermatitisNot yet recruitingNCT07162896Phase 3
- Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell TransplantationRecruitingNCT07162038Phase 1
- Role of Methotrexate in Ultrasound Proven Synovitis in Primary Knee OARecruitingNCT07161336Phase 2
- A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune DiseasesRecruitingNCT07144462Early Phase 1
- Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyRecruitingNCT07138898Phase 2
- Tacrolimus Eye Drops in Treatment of Vernal KeratoconjunctivitisNot yet recruitingNCT07138742Not applicable
- Anlotinib Hydrochloride Capsules in Maintenance Treatment for Intermediate-High Risk Rhabdomyosarcoma in ChildrenNot yet recruitingNCT07137884Phase 2
- Sirolimus Discontinuation Strategies in Kaposiform HemangioendotheliomaRecruitingNCT07131644Phase 2
- Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory LeukemiaNot yet recruitingNCT07120607Phase 1
- A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune DiseasesRecruitingNCT07115745Phase 1
- Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous DiseaseEnrolling by invitationNCT07113743Phase 1/2
- HS-IT101 Injection for Advanced NSCLC(FASTIL-Lung01)RecruitingNCT07105176Phase 1
- Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)RecruitingNCT07101432Phase 1
- Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin LymphomaRecruitingNCT07097363Phase 2
- The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory EpilepsyRecruitingNCT07095933Early Phase 1
- Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-CessationRecruitingNCT07092618Phase 2/3
- GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young AdultsRecruitingNCT07087002Phase 1
- Genetic Variation in TRAF3IP2 (rs13190932)RecruitingNCT07086924Not applicable
- A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune DiseaseRecruitingNCT07085104Phase 1
- Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment InterruptionNot yet recruitingNCT07081763Phase 2
- The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)RecruitingNCT07065968Phase 2
- A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.RecruitingNCT07062965Phase 3
- Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate CancerRecruitingNCT07056790Phase 1/2
- A Phase 1 Open-Label, Dose-Ranging Safety and Pharmacokinetics Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)Not yet recruitingNCT07053020Phase 1/2
- Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need VentilatorsRecruitingNCT07052929Phase 1/2
- An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular MalformationsRecruitingNCT07037238Phase 2
- Evaluaion the Short Term Effects of Advograf Plus Rapamiune After Kidney TransplantationRecruitingNCT07033858Not applicable
- A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous NephropathyNot yet recruitingNCT07029139Phase 2
- Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid TumorsRecruitingNCT07010523Not applicable
- Effects Of Intra-Operative Intra-Articular Cocktail Injection In Patella Open Reduction And Internal FixationRecruitingNCT07006168Phase 4
- BrECADD Therapy in Stage 2 B-IV Hodgkin LymphomaRecruitingNCT07002216Phase 2
- Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States PopulationRecruitingNCT06997068Phase 2
- Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell TransplantRecruitingNCT06996119Phase 1
- CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic DifferentiationNot yet recruitingNCT06986434Early Phase 1
- Phase 1b/2a Trial of Allogeneic HSCT From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset Medically Refractory Crohn DiseaseNot yet recruitingNCT06986382Phase 1/2
- Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)RecruitingNCT06983821Phase 3
- ZR-MTX for PIOL Phase II TrialRecruitingNCT06973811Phase 2
- Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19RecruitingNCT06960928Phase 3
- Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient StudyRecruitingNCT06959771Phase 1/2
- Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)RecruitingNCT06954805Phase 2
- Comparing Effectiveness of Steroids and Methotrexate in Treatment of Chronic Inflammatory Breast DiseaseNot yet recruitingNCT06943482Phase 4
- Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in KoreaNot yet recruitingNCT06942156Phase 4
- Pragmatic, Open-Label Study to Pilot Evaluation for Clinical Trials in Relapsing PolychondritisRecruitingNCT06941376Phase 2
- A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast CancerNot yet recruitingNCT06941142Phase 1
- Additional Effect of Steroid on Hyaluronic Acid in Subdeltoid BursitisNot yet recruitingNCT06935877Phase 4
- Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 InhibitorsNot yet recruitingNCT06929325Phase 3
- Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD PreventionRecruitingNCT06926595Phase 2
- Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic SyndromesRecruitingNCT06923488Phase 1/2